等待開盤 09-25 09:30:00 美东时间
-0.550
-6.86%
今日重点评级关注:Ascendiant Capital:维持Allarity Therapeutics"买入"评级,目标价从10.25美元升至11美元;Needham:上调Rocket Pharmaceuticals"买入"评级,目标价9美元
09-17 16:16
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Seaport Global analyst Eric Gonzalez initiated coverage on McDonald’s Corp (NYSE:MCD) with a Neut...
09-16 20:14
今日重点评级关注:Ascendiant Capital:维持SurgePays"买入"评级,目标价从3.5美元升至3.75美元;HC Wainwright & Co.:维持Spero Therapeutics"买入"评级,目标价从5美元升至6美元
09-15 15:30
HC Wainwright & Co. analyst Arthur He reiterates Solid Biosciences (NASDAQ:SLDB) with a Buy and maintains $25 price target.
09-14 19:40
Solid Biosciences Inc. announced its participation in three upcoming investor conferences in September 2026. CEO Bo Cumbo and CMO Gabriel Brooks will attend the 2026 Cantor Global Healthcare Conference on September 9 and the 2026 Citi Biopharma Back to School Conference on September 10. Cumbo will also participate in the H.C. Wainwright 28th Annual Global Investment Conference on September 14. Live webcasts and 90-day replays of each fireside cha...
09-02 12:00
今日重点评级关注:Ascendiant Capital:维持PAVmed"买入"评级,目标价从56美元升至57美元;Ascendiant Capital:维持Lucid Diagnostics"买入"评级,目标价从9.25美元升至9.5美元
08-28 16:15
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Evercore ISI Group raised the price target for Salesforce Inc (NYSE:CRM) from $250 to $290. Evercore ISI Group...
08-27 21:19
今日重点评级关注:摩根士丹利:维持Ultragenyx Pharmaceutical"超配"评级,目标价从67美元升至74美元;Truist Securities:维持Solid Biosciences"买入"评级,目标价从16美元升至20美元
08-24 16:40
Truist Securities analyst Danielle Brill maintains Solid Biosciences (NASDAQ:SLDB) with a Buy and raises the price target from $16 to $20.
08-22 01:30
U.S. stock futures were mixed this morning, with the Dow futures falling around 0.1% on Monday. Shares of Airsculpt Technologies Inc (NASDAQ:AIRS) fell sharply in pre-market trading following second-quarter results. AirSculpt Technologies posted second-quarter adjusted earnings of 1 cent per share, ...
08-10 20:02